The Globalized Food Industry in Mexico |
Laura Schmidt, PhD |
Mexico |
|
|
Promoting Woman-Centered, Rights-Based Client-Provider Interactions: Adaptation and Dissemination of the Quality of Contraceptive Counseling Scale |
Kelsey E. Holt, ScD |
Ethiopia, India, Mexico |
|
|
Relationship Attitudes among Pregnant Adolescents and Adolescent Mothers in Guanajuato, Mexico and Fresno, California: A Qualitative Study |
Tannia MacKethan, MS |
Mexico |
|
|
Leveraging mosquito antiviral immunity to detect viral infections: Towards a scalable field-based approach for predicting arbovirus epidemics |
Raul Andino-Pavlovsky, PhD |
Mexico |
|
|
Improving Diabetes Counselling Guides for Post-Partum Latina Moms |
Margaret Handley, PhD, MPH |
Mexico |
|
|
Intervention for attention deficit hyperactivity disorder |
Lauren Haack, PhD, MD, MPH |
Mexico |
|
|
Open Tibia Research Project |
Theodore Miclau, MD |
Costa Rica, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela, Cuba |
|
|
Validation of a Scale to Measure the Quality of Contraception Counseling |
Kelsey E. Holt, ScD |
Mexico |
|
|
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects |
Camila Hurtado, MS |
Mexico |
|
|
Community Engagement for Diabetes Management and Prevention: A Cost Analysis at Tiopa Community Health Clinic |
Katie Morales, MSN, MS |
Mexico |
|
|
Impact of Health Literacy Interventions on Outcome of Patients with Diabetes and Hypertension in Latin America and the Caribbean: A Systematic Review |
Lucia Abascal, MD, MS |
Mexico |
|
|
A cross-national perspective on social integration and cognitive aging for Mexican-origin adults in the U.S. and Mexico: Quantifying the effects of both local and cross-border social integration |
Jacqueline Torres, PhD |
Mexico |
|
|
Substance abuse in vulnerable populations |
Meredith Meacham, PhD |
Mexico |
|
|
Outcomes of pregnant and parenting adolescents |
Abigail Gutmann-Gonzalez, MPH |
Mexico |
|
|
Global Anesthesia Capacity Assessment Tools |
|
Mexico |
|
|
Achieving Global Malaria Eradication through Accelerated Regional Elimination |
Richard Feachem, DSc, PhD |
Sao Tome and Principe, Algeria, Botswana, Namibia, South Africa, Swaziland, Cape Verde, Tajikistan, China, North Korea, South Korea, Bhutan, Iran, Nepal, Sri Lanka, Viet Nam, Malaysia, Thailand, Philippines, Azerbaijan, Saudi Arabia, Turkey, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Solomon Islands, Vanuatu |
|
|
HEAL Initiative |
Phuoc V. Le, MD, MPH, DTM+H |
Malawi, Liberia, India, Nepal, Mexico, Haiti |
|
|
MicroRNAs Circulantes Asociados Con Riesgo De Diabetes En Latinos |
Elena R. Flowers, PhD, RN |
Mexico |
|
|
Molecular Basis of Hereditary Retinal Degenerations |
Jacque Duncan, MD |
India, Pakistan, Mexico |
|
|
Ultrasound training in resource poor settings |
Jeanne Noble, MD |
Mexico |
|
|
Improving care for vulnerable populations |
Marlene Martin, MD |
Nepal, Mexico |
|
|
HEAL Initiative |
Phuoc V. Le, MD, MPH, DTM+H |
Kenya, Malawi, Rwanda, Uganda, Tanzania, Liberia, Nepal, Philippines, Mexico, Haiti |
|
|
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START |
Richard Price, MD |
Uganda, Morocco, South Africa, Mali, Nigeria, China, Japan, India, Malaysia, Thailand, Israel, Mexico, Brazil, Chile, Peru, Uruguay, Australia |
|
|
Providing Environmental Health Information to Healthcare Providers along the Region 9 US-Mexico Border |
Timur Durrani, MD, MPH, MBA |
Mexico |
|
|
Individual, social, and structural factors on disease transmission in marginalized populations |
Meghan Morris, PhD, MPH |
Tanzania, Namibia, Mexico, Jamaica, Australia |
|
|
Health systems analysis |
John Peabody, MD, PhD |
Philippines, Mexico |
|
|
Executive Director of UCSF Global Health Sciences |
Jaime Sepulveda, MD, DSc, MPH |
Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zimbabwe, Mexico |
|
|
Transcriptional rewiring of aging pathways and dietary restriction effects in yeasts |
|
Mexico |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Ethiopia, Kenya, Mozambique, Uganda, Tanzania, Zimbabwe, China, Bangladesh, India, Ukraine, Guatemala, Mexico, Panama, Brazil, Chile, Peru |
|
|
Office of the UN Special Envoy for Tuberculosis |
Eric Goosby, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Central Asia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, South Korea, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Caribbean, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 |
George Rutherford, MD |
Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu |
|
|
Auranofin supplies to test as a macrofilaricide for human onchocerciasis |
Jaime Sepulveda, MD, DSc, MPH |
Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Charles Chiu, MD, PhD |
Rwanda, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Gabon, China, Bangladesh, Nepal, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Thailand, Mexico, Bolivia, Brazil, Peru |
|
|
Project Nino |
Mansi Desai, MD |
Mexico |
|
|
Heal Initiative |
Phuoc V. Le, MD, MPH, DTM+H |
Liberia, India, Nepal, Mexico, Haiti |
|
|
Global Orthopaedics and Traumatology (IGOT) |
Theodore Miclau, MD |
Mexico, Cuba |
|
|
Global Brain Health Institute |
Victor Valcour, MD, PhD |
South Africa, Viet Nam, Turkey, Greece, Mexico, Argentina, Brazil, Cuba, Dominican Republic |
|
|
Child Family Health International (CFHI) |
Jessica Evert, MD |
Uganda, Tanzania, South Africa, Ghana, India, Philippines, Mexico, Argentina, Bolivia, Ecuador |
|
|
Orthopedic Surgery and Anesthesia access in underserved areas |
John Feiner, MD |
Mexico, Nicaragua, Bolivia, Ecuador, Dominican Republic |
|
|
Compañeros en Salud in Chiapas, Mexico |
Patrick Newman, MD, MPH |
Mexico |
|
|
Enhancing Mexican Capacity for CVD Policy Research |
Alicia Fernandez, MD |
Mexico |
|
|
Heal Initiative |
Sriram Shamasunder, MD |
Malawi, Liberia, Mali, India, Nepal, Mexico, Haiti |
|
|
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica |
|
|
Chlamydial sexually transmitted diseases and trachoma |
Deborah Dean, MD, MPH |
Nepal, Viet Nam, Thailand, Guatemala, Mexico, Nicaragua, Ecuador |
|
|
Fighting Infections through Research, Science and Technology (FIRST) Service Contract |
Jaime Sepulveda, MD, DSc, MPH |
Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama |
|
|
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma |
Esteban Burchard, MD, MPH |
Mexico, Puerto Rico |
|
|
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 |
Mandana Khalili, MD |
South Korea, Japan, India, Singapore, Belgium, Finland, France, Greece, Italy, Netherlands, Russia, United Kingdom, Mexico, Argentina, Brazil, Chile, Canada, Australia, New Zealand |
|
|
Enhancing Mexican Capacity for Cardiovascular Disease (CVD) Policy Research |
Kirsten Bibbins-Domingo, MD, PhD |
Mexico |
|
|
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26- Year-Old Men and 16- to 26- Year-Old Women |
Joel Palefsky, MD |
South Africa, Malaysia, Thailand, Israel, Turkey, Denmark, Germany, Norway, Poland, Spain, Sweden, Mexico, Colombia, Peru, Canada |
|
|
Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder |
|
Germany, Hungary, Italy, Romania, Spain, Sweden, Mexico, Canada |
|
|
Addressing Abortion Stigma Through Service Delivery |
Ushma Upadhyay, PhD, MPH |
Kenya, Uganda, Zambia, Ghana, India, Mexico |
|
|
Fighting Infections through Research, Science and Technology (FIRST) Phase 1 and 2: Creating a Partnership to Fight Neglected Infectious Disease in Mesoamerica |
Jaime Sepulveda, MD, DSc, MPH |
Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama |
|
|
WHO Adolescent HTC Review Update (PO# 200660799) |
George Rutherford, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu |
|
|
Escaneo genomico completo del paciente con diabetes tipo 2 para la busqueda de nuevos marcadores de asociacion con enfermedad |
Esteban Burchard, MD, MPH |
Mexico |
|
|
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel |
Charles Chiu, MD, PhD |
China, Bangladesh, Indonesia, Malaysia, Mexico, Brazil, Colombia |
|
|
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial |
Nisha Acharya, MD |
India, Mexico, Australia |
|
|
Comparative Effectiveness of Policies to Reduce Dietary Salt Intake in the Pacific Rim |
Kirsten Bibbins-Domingo, MD, PhD |
China, Mexico, Argentina, Chile |
|
|
Lifetime trauma exposure, Chronic Pain, Depression and PTSD in Mexican women: A pilot study |
|
Mexico |
|
|
RNA Interference and High-Content Image Analysis to Discover New Drug Targets to Treat the Tropical Disease Schistosomiasis |
|
Mexico |
|
|
Enhancing Mexican Capacity for Cardiovascular Policy Research |
Kirsten Bibbins-Domingo, MD, PhD |
Mexico |
|
|
Master Member Agreement: Translational Breast Cancer Research Consortium |
|
Egypt, Greece, Mexico, Peru |
|
|
Viral Discovery in Human and Animal Samples |
Charles Chiu, MD, PhD |
Rwanda, Uganda, Tanzania, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Gabon, China, Bangladesh, Nepal, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Thailand, Mexico, Bolivia, Brazil, Peru |
|
|
Epidemiology and clinical manifestations of chlamydial infections |
Julius Schachter, PhD |
Ethiopia, Niger, India, Nepal, Thailand, Mexico |
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Christopher Stewart, MD |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus |
Mandana Khalili, MD |
Mexico, Argentina, Puerto Rico, Australia |
|
|
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program |
Craig Cohen, MD, MPH |
Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu |
|
|
BMS-790052 with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 1 |
Mandana Khalili, MD |
Egypt, Sweden, Mexico, Puerto Rico, Canada, Australia |
|
|
Clients' Experiences with Legal Abortion Services in Mexico City: Support for Dissemination Activities |
Cynthia Harper, PhD |
Mexico |
|
|
Consortium of Universities of Global Health (CUGH) - Leading the Way |
Haile Debas, MD |
Ethiopia, Kenya, Tanzania, Zambia, Egypt, Botswana, Namibia, South Africa, Ghana, Mali, China, India, Pakistan, Viet Nam, Thailand, Israel, Mexico, Chile, Peru, Jamaica, Trinidad and Tobago |
|
|
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens |
Charles Chiu, MD, PhD |
Uganda, India, Mexico |
|
|
TB TO 2015 |
Philip Hopewell, MD |
Ethiopia, Kenya, Tanzania, Botswana, China, India, Nepal, Indonesia, Thailand, Mexico |
|
|
Consortium of Universities of Global Health (CUGH) |
Haile Debas, MD |
Ethiopia, Kenya, Uganda, Tanzania, Zambia, Egypt, Botswana, Namibia, Ghana, Mali, China, India, Pakistan, Viet Nam, Thailand, Israel, Czech Republic, Guatemala, Mexico, Chile, Peru, Jamaica, Trinidad and Tobago |
|
|
Strengthening Indigenous Food Identity and Minimizing Chronic Disease Risk |
Margaret Handley, PhD, MPH |
Mexico |
|
|
Research Training in International Transfusion Safety |
Edward Murphy, MD, MPH |
South Africa, France, Honduras, Mexico, Argentina, Brazil |
|
|
Conducting Infection Control Assessment and Developing Educational Materials for Mexico |
Philip Hopewell, MD |
Mexico |
|
|
CAPS/Fogarty Visiting Scientists and In-Country Research Training Activities |
George Rutherford, MD |
Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zambia, Zimbabwe, Egypt, Sudan, South Africa, Burkina Faso, Ghana, Nigeria, Senegal, Kazakhstan, China, Japan, India, Iran, Nepal, Cambodia, Indonesia, Viet Nam, Thailand, Philippines, Georgia, Jordan, Croatia, Czech Republic, Russia, Costa Rica, Guatemala, Mexico, Argentina, Brazil, Chile, Ecuador, Peru, Venezuela, Dominican Republic, Puerto Rico, Trinidad and Tobago, Canada |
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Haile Debas, MD |
Kenya, Uganda, Tanzania, Botswana, Lesotho, South Africa, Thailand, Guatemala, Mexico, Nicaragua, Brazil |
|
|
University Consortium for Global Health |
Haile Debas, MD |
Ethiopia, Kenya, Tanzania, Zambia, Egypt, Botswana, Namibia, South Africa, Ghana, Mali, China, India, Pakistan, Viet Nam, Thailand, Israel, Mexico, Chile, Peru, Jamaica, Trinidad and Tobago |
|
|
Congenital Syphilis Elimination Cost-Effectiveness Analysis |
James Kahn, MD, MPH |
Burundi, Comoros, Djibouti, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Brazzaville), Gabon, Sao Tome and Principe, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Ghana, Guinea, Mali, Nigeria, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Uzbekistan, China, Mongolia, Afghanistan, Bangladesh, India, Maldives, Nepal, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Philippines, Jordan, Oman, Saudi Arabia, Belarus, Czech Republic, Estonia, Germany, Hungary, Lithuania, Macedonia, Moldova, Romania, United Kingdom, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Uruguay, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Trinidad and Tobago, Fiji, Kiribati, Papua New Guinea |
|
|
Metagenomics for Detection and Discovery of Viruses Associated with Acute Gastroenteritis in Mexico |
Charles Chiu, MD, PhD |
Mexico |
|
|
Molecular Epidemiology of the Human Immunodeficiency Virus in Mexico |
|
Mexico |
|
|
Sangre Segura: An Epidemiological Study of Blood Transfusion Safety in the Mexico-U.S. Border Region |
Edward Murphy, MD, MPH |
Mexico, United States |
|
|
Whole Genome Analyses for Asthma in Latino Populations |
Esteban Burchard, MD, MPH |
Mexico, Puerto Rico |
|
|
Oral Health is Global Health |
John Greenspan, BDS, PhD |
Nepal, Cambodia, Viet Nam, Philippines, Guatemala, Honduras, Mexico, Peru, Haiti, Jamaica, Micronesia, Vanuatu |
|
|
Public Health Trust Lead in Mexican Candies Grant Program - Education Materials |
Stuart Heard, PharmD |
Mexico |
|
|
Global Health Sciences Clinical Scholars Program Immersion Experience |
Haile Debas, MD |
Kenya, Uganda, Tanzania, Botswana, Lesotho, South Africa, Thailand, Guatemala, Mexico, Nicaragua, Brazil, Peru |
|
|
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT |
Steven Deeks, MD |
Uganda, South Africa, Mali, Nigeria, China, Malaysia, Thailand, Mexico, Argentina, Brazil, Chile, Peru, Uruguay |
|
|
ATS Implementation Guide and Training Modules |
Philip Hopewell, MD |
Kenya, Tanzania, China, India, Nepal, Indonesia, Mexico |
|
|
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica |
|
Mexico |
|
|
Institute for Global Orthopedics and Traumatology (IGOT) |
Richard Coughlin, MD |
Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Seychelles, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Egypt, Morocco, Botswana, Namibia, South Africa, Ivory Coast, Ghana, Liberia, Mali, Niger, Nigeria, Sierra Leone, Kazakhstan, Tajikistan, Uzbekistan, China, Afghanistan, Bangladesh, India, Nepal, Viet Nam, Thailand, Philippines, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Brazil |
|
|
AHEC/HETC - California Border Health Education Training Center |
|
Mexico |
|
|
Case Series of ASG Device in Nigeria and Mexico |
Suellen Miller, PhD, CNM, MHA |
Nigeria, Mexico |
|
|
UCSF-Mexico Collaborative International Health Program in Internal Medicine |
John Peabody, MD, PhD |
Mexico |
|
|